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Objectives: To describe participants’ adherence to multiple components (attendance, energy 
intake, fat gram, exercise goals, and self-monitoring eating and exercise behaviors) of a standard 
behavioral treatment program (SBT) for weight loss and how adherence to these components 
may influence weight loss and biomarkers (triglycerides, low density lipoproteins [LDL], high 
density lipoprotein, and insulin) during the intensive and less-intensive intervention phases.
Methods: A secondary analysis of a randomized clinical trial consisting of a SBT with either 
fat-restricted standard or lacto-ovo vegetarian diet. The 12-month intervention was delivered 
in 33 group sessions. The first six months reflected the intensive phase; the second six months, 
the less-intensive intervention phase. We conducted the analysis without regard to treatment 
assignment. Eligible participants included overweight/obese adults (N = 176; mean body mass 
index = 34.0 kg/m2). The sample was 86.9% female, 70.5% White, and 44.4 ± 8.6 years old. 
The outcome measures included weight and biomarkers.
Results: There was a significant decline in adherence to each treatment component over 
time (P  0.0001). In the first six months, adherence to attendance, self-monitoring and the 
energy goal were significantly associated with greater weight loss (P  0.05). Adherence to 
attendance and exercise remained significantly associated with weight loss in the second six 
months (P  0.05). Adherence to attendance, self-monitoring and exercise had indirect effects 
through weight loss on LDL, triglycerides, and insulin (P  0.05).
Conclusions: We observed a decline in adherence to each treatment component as the 
intervention intensity was reduced. Adherence to multiple treatment components was associated 
with greater weight loss and improvements in biomarkers. Future research needs to focus on 
improving and maintaining adherence to all components of the treatment protocol to promote 
weight loss and maintenance.
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Obesity is a chronic disorder with a prevalence rate that continues to increase in some 
population groups. Efforts to improve weight loss have focused on standard behavioral 
treatment (SBT) programs that require lifestyle changes such as adopting healthy 
eating and exercise patterns.1 Adopting these patterns requires committing to major 
behavioral changes, making long-term adherence a challenge. Declining adherence 
during or after a SBT program results in high rates of weight regain.2
Although success in any weight-loss program requires adhering to the study 
protocol and successfully implementing and maintaining lifestyle change, detailed 
measurement of adherence has been reported infrequently; thus, little is known about 
the extent to which people adhere to the components of an SBT program. We defined 
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adherence as the extent to which a participant’s behavior in 
making lifestyle changes coincided with the study protocol. 
Reported measures of adherence in the literature include 
periodic three-day food records,3–5 a dietary assessment 
questionnaire,6,7 diary recordings of the amount of exercise 
performed,6 rates of adherence to the treatment protocol as 
reported in interviews,8 and rates of attendance at the inter-
vention sessions.9,10 However, few investigators report adher-
ence, and as noted here, the measures vary greatly, making 
it difficult to compare adherence across studies.
Greater adherence to treatment has been associated with 
improved clinical outcomes and prevention or reduction 
of complications.11–14 Self-monitoring, or keeping track 
of food and exercise behaviors, has been found to result 
in greater weight loss among various populations seeking 
weight loss.12,15,16 Similarly, a positive association between 
the number of intervention sessions attended and weight loss 
has been reported.10,13 A relationship between adherence to 
physical activity regimens and weight loss has also been 
reported.6,17 However, these studies had several limitations, 
particularly a limited sample size12 and a brief intensive 
intervention period.12,15 Because adherence varies over time, 
it is important to examine the pattern of adherence to treat-
ment following the intensive phase intervention as well as 
the effect of adherence on clinical outcomes in a relatively 
larger sample.
Although the SBT program requires adherence to multiple 
components of the intervention, many studies report only 
one or two measures of adherence, such as attendance,10,13 
dietary adherence,11 or physical activity adherence.6 Hence, 
little is known about the pattern of adherence to the various 
components of a weight loss intervention during the inten-
sive and less-intensive phases. Many weight loss studies 
have reported changes in biomarkers during the intervention 
period.18 However, none has examined the effects of adher-
ence to treatment components on biomarkers.
We conducted an 18-month randomized clinical trial 
(PREFER; Paving the road to everlasting food and exercise 
routine) that used a 2 × 2 factorial design comparing the effects 
of two dietary options; standard weight loss diet (STD-D) vs 
lacto-ovo-vegetarian diet (LOV-D) by whether or not subjects 
received their preferred dietary treatment (Preference-Yes 
versus Preference-No).19 This paper describes participants’ 
adherence to multiple components of an SBT program for 
weight loss: session attendance, dietary goals (calories and fat 
grams), exercise goals, and self-monitoring eating and exer-
cise behaviors, and the effect of each component of adherence 
on weight change and biomarkers (triglycerides, low density 
lipoproteins [LDL], high density lipoprotein [HDL], and 
insulin) during the intensive (0–6 months) and less-intensive 
(7–12 months) phases of the intervention. Since we observed 
no differences in adherence to the components of the 
treatment protocol and weight, and biomarker changes by the 
four treatment combinations utilizing the assessment data,20,21 
this secondary analysis was conducted as a single sample 
without regard to randomized diet or preference treatment 
utilizing the process data.
Methods
The design, recruitment and randomization procedures have 
been described in detail elsewhere.19 The study protocol was 
approved by the University of Pittsburgh Institutional Review 
Board. All participants provided written informed consent.
Participants
A total of 932 individuals were screened for eligibility by 
phone and subsequent questionnaires. Eligibility criteria 
required that individuals were between 18 and 55 years of 
age; had a body mass index (BMI) between 27 and 43 kg/m2 
inclusively; and had completed a five-day food diary at 
screening. Individuals were excluded if they had a current 
medical condition requiring physician supervision of diet or 
physical activity; were pregnant or had intention to become 
pregnant during the study period; were receiving pharmaco-
logical treatment that might affect weight; reported alcohol 
intake of 4 drinks/day; were participating in any weight-
loss program in the last six months; or reported abstention 
from eating meat, poultry, or fish in the past month.
After completion of the screening phases and baseline 
assessment, 200 participants were stratified by gender, 
ethnicity and diet preference and randomly assigned to 
1 of 4 groups through a two-stage randomization scheme: 
Preference-Yes + STD-D (n = 63); Preference-Yes + LOV-D 
(n = 36); Preference-No + STD-D (n = 50) and Preference-
No + LOV-D (n = 48). Fifteen individuals had to be excluded 
from Preference-Yes + STD-D diet to obtain a fair balance 
in size across the groups. Nine participants were excluded 
during the study because they no longer met eligibility 
criteria, eg, pregnancy, diabetes. Of a total of 176 partici-
pants who participated in the treatment sessions initially, the 
current analysis included 151 participants who attended the 
assessment visits.
intervention
All four treatment groups received the common components 
of the standard behavioral intervention: (1) group sessions, 
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(2) daily energy goal, (3) daily fat gram goal, (4) weekly 
exercise/physical activity goal (minutes), and (5) self-
monitoring eating and exercise behaviors. The only differ-
ence between the diet groups was that the LOV-D participants 
were instructed to eliminate meat, poultry, and fish from their 
diet by the sixth week of the program.
group sessions
Participants attended closed group sessions weekly during 
the intensive phase in the first six months. The less-intensive 
phase consisted of biweekly meetings for months 7–9 
and monthly meetings for months 10–12. This 12-month 
treatment phase was followed by a six-month maintenance 
phase with no contact by study staff until the final 18-month 
assessment. The evening sessions lasted approximately an 
hour. The cognitive-behavioral intervention used several 
strategies from models of motivation and behavior change. 
Sessions focused on behavioral strategies for modifying 
one’s lifestyle and adopting healthy eating and physical 
activity behaviors and included a wide range of topics from 
information on general health/nutrition/exercise to practical 
hands-on experiences to develop skills, such as label reading, 
food shopping, and using low-fat cooking methods. The same 
multidisciplinary team (behavioral scientist, nutritionist, and 
exercise specialist) led these sessions. Further details of the 
intervention have been reported elsewhere.19
Several approaches used to promote attendance and reten-
tion included contacting participants who missed a session 
the next day and conducting a make-up session when pos-
sible. If a participant missed two consecutive sessions, we 
sent a letter offering an individual make-up session. If the 
participant could not attend, we sent session materials and 
when possible, we exchanged diaries. Incentives to promote 
attendance included receiving either Cooking Light for the 
STD-D group or Vegetarian Times magazine for the LOV-D 
group at the session.
energy and fat gram goals
Each participant received a daily energy and fat gram 
goal based on gender and baseline body weight. For those 
weighing 200 lbs, the prescribed daily total energy intake 
was 1200 calories for women and 1500 calories for men. For 
those weighing 200 lbs, it was 1500 calories for women 
and 1800 calories for men. The fat gram goal was 25% of 
the total daily calories, eg, 33 or 42 grams/day for females 
and 42 or 50 grams/day for men.
The interventionists counseled participants to ensure 
that their average daily consumption over a one-week 
period stayed within the energy and fat gram goals; thus, if 
a participant knew that a social event may lead to exceeding 
the calorie/fat gram goals one day, he/she was encouraged 
to eat less than the dietary goals on other days that week so 
the week’s total would be within the goal. This strategy is 
referred to as banking calories and fat grams.
exercise goal
Participants were instructed to increase their physical activity 
gradually, primarily via walking, until they reached a goal of 
150 minutes per week by the sixth week. As an alternative to 
walking, aerobic activities such as bicycling, swimming, and 
jogging were encouraged. We promoted the use of frequent, 
short bouts to meet one’s exercise goal, eg, exercise for 
10–15 minutes three times per day.
self-monitoring
This was a central behavior change strategy used to increase 
the participants’ awareness of their eating behaviors, the 
foods consumed, and their physical activity levels. We 
instructed participants to record in a paper-and-pencil diary 
all the foods consumed with the corresponding number of 
energy and fat grams, as well as physical activity duration 
(minutes) and type. They were provided a reference book 
with nutrient information and were taught how to look up 
energy and fat gram content for food items when food labels 
were unavailable. They also calculated subtotals after each 
dietary entry or at least periodically throughout the day, to 
compare intake values to their daily goals, and make dietary 
and physical activity adjustments accordingly. We provided 
each participant who turned in the completed food and 
exercise diary a new diary for the next week at each session. 
The interventionist reviewed the completed diary, provided 
written feedback, and returned it at the next session.
Measures of adherence
Attendance at group sessions
Attendance was examined as a binary variable (adherent:
attended, nonadherent:not attended).
Adherence to energy and fat gram goals
We calculated adherence to energy and fat gram goals on a 
weekly basis to incorporate the banking strategy. Adherence 
to the energy goal was calculated by dividing the total number 
of energy consumed per week by the weekly calorie goal, 
then multiplying by 100 to express the value as a percentage, 
eg, if a participant with a daily calorie goal of 1800 (weekly 
goal = 12,600) reported consuming 10,500 total calories in a 
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week, the level of adherence to the energy goal was calculated 
as 83.3% (10,500/12,600 × 100%). We calculated the level 
of adherence to the fat gram goal similarly.
Based on the calculation of adherence to the energy intake 
and fat gram goals, participants were categorized as adherent 
(reported consuming 85%–115% of the weekly goals) and 
nonadherent (reported consuming 85% or 115% of the 
weekly goals) on a weekly basis. It is important to note that 
participants were categorized for energy and fat gram goals 
separately; thus, a person could be adherent to the dietary goal 
in one dimension (energy) and not in another (fat grams). If 
a diary was not returned, adherence to dietary goals (energy 
and fat grams) was coded as nonadherent for that week.
Adherence to exercise goal
We calculated exercise adherence using the reported weekly 
minutes spent exercising divided by the weekly goal. For 
example, a person who reported 140 minutes when the goal 
was 150 minutes a week, adherence to the goal was 93% 
(140/150 × 100%). Since the exercise goal was increased over 
the first six weeks, the denominator was changed accordingly. 
Adherence to the goal was examined as a binary variable 
based on whether participants achieved the goal each time 
their diaries were submitted (adherent: 100% of weekly 
goal, nonadherent: 100% of weekly goal).
Adherence to self-monitoring
We examined adherence to self-monitoring as a binary 
variable based on whether participants completed daily 
recordings of food, energy intake and fat grams in the 
weekly diary (adherent:self-monitored, nonadherent:did not 
self-monitor). We defined an incomplete or a missing diary 
as nonadherent for that week. Participants were expected to 
complete 32 diaries during the intervention period.
Outcome measures
At each intervention session, we measured weight on a 
digital scale (Tanita Corporation of America, Inc., Arlington 
Heights, IL, USA) with the participant in light clothing and 
not wearing shoes. This scale is widely used in the research 
and is known to provide valid measures of weight and body 
composition. Additionally, the scale was calibrated periodi-
cally to ensure reliability.
Blood samples, obtained following a 12-hour fast every 
six months, were assayed at the Heinz Nutrition Laboratory, 
University of Pittsburgh. Analyses of serum triglyceride and 
HDL levels were conducted enzymatically using the Abbot 
VP Supersystem. LDL was estimated using the Friedwald 
equation. Insulin was measured by radioactive immunoassay 
procedure.
statistical methods
We used SAS (version 9.1.3; SAS Institute, Inc., Cary, NC) 
to conduct the statistical analyses. The significance level for 
two-sided hypothesis testing was set at 0.05. We computed 
descriptive statistics as means and standard deviations, or 
medians and interquartile ranges for continuous variables and 
frequency counts and percentages for categorical variables. 
Wilcoxon rank-sum and two sample t-tests for continuous 
variables and chi-squared tests of independence for categori-
cal variables were used to compare baseline characteristics of 
the participants included in the analysis and those excluded 
from the analysis due to missing data from the treatment 
sessions or the semi-annual assessments.
Weight measurements were missing for some sessions 
due to attrition that occurred at different time points. For 
missing session weights, we used the difference in weight 
from the last to the next attended session and distributed 
that weight difference equally over the number of missed 
sessions. Participants who attended at least 50% of the 
sessions were included in the examination of the effects 
of the five components of adherence on the percent weight 
change (n = 139 at six months and n = 106 at 12 months). 
Participants missing the 6th or 12th month weight assessment 
were excluded from examination of the effects of adherence 
on percent biomarker changes (n = 25).
Because adherence to each treatment component was 
treated as a binary response, nonlinear mixed effects 
modeling was applied (PROC NLMIXED) to model adher-
ence as a function of time. Mixed-effect logistic regression 
modeling was employed for the longitudinal binary response 
variables of adherence to attendance, exercise, self-moni-
toring, and calorie and fat gram goals with the probability 
of being adherent (=1) being modeled.22 Both linear and 
nonlinear functions of time (eg, square root, squared, and 
cube) were considered. We used the likelihood ratio test to 
compare nested models. Nonsignificant functions of time 
were eliminated to achieve parsimonious models.
To test the effects of components of adherence on percent 
weight change over time, we used linear mixed modeling 
(PROC MIXED). We excluded adherence components 
from the full multivariate model if they were not statistically 
significant in the univariate analyses or did not significantly 
improve the model. Using the Akaike information criterion 
and the Bayesian information criterion, the heterogeneous 
Toeplitz covariance structure was identified as having the best 
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fit for the variance/covariance for the repeated assessments 
for weight.
For the examination of the mediating effects of weight 
loss on adherence components, we calculated the proportion 
of weeks that participants were adherent for each component 
by dividing the number of completed diaries by the total 
number of sessions in each six-month period. Percent change 
was considered for weight and biomarkers. We used the Sobel 
test via bootstrapping23 to examine the mediating effect of 
percent weight change as described in Figure 1. Sensitivity 
analyses were performed to assess data points that were 
outliers and/or were influential. These observations were 
detected by graphical analysis of residuals. When outlying 
observations were omitted via sensitivity analysis, the results 
did not change, supporting the robustness of our findings.
Results
The PREFER sample was predominantly female (86.9%), 
White (70.5%), currently employed (63.1%), and on average, 
completed 15 years of formal education. The mean age was 
44.4 ± 8.6 years with a BMI range of 27.1 kg/m2 to 42.7 kg/m2 
at baseline. Table 1 described the mean weight and measures 
of biomarkers of participants included in the analysis.
Adherence to treatment protocol
Figure 2 displays the overall pattern of adherence to all 
components of the treatment protocol over time. Attendance 
had the highest level of  adherence followed by self-monitoring, 
and achieving the exercise, energy and fat gram goals during 
the entire intervention period. Attendance decreased to 56% 
at the end of the first six months and to 44% at the end of 
12 months. Half of the sample continued to self-monitor at 
six months and 22% at the end of the year. On average, 62% 
of the diaries were turned in and of those diaries, 93.2% of 
them contained completed recordings. We observed a sharp 
decline in adherence to the exercise at week six, the point 
where the goal increased to 150 minutes per week, and 
observed a continuing decline thereafter. The highest level 
ADHERENCE
Predictor Variable
BIOMARKERSTotal Effect
Total effect of adherence on biomarkers
(no controlling for weight ∆)  
The effect of adherence on biomarkers
(controlling for weight ∆)  
Response Variable
A
WEIGHT CHANGE
Mediator
ADHERENCE
Predictor Variable
BIOMARKER
Response Variable
Effect of adherence on
weight ∆ 
Effect of weight ∆ on
biomarkers controlling for
adherence    
Direct Effect
Indirect Effect
(through weight ∆) 
B
Figure1 Direct and indirect effects of adherence measures on changes in biomarkers.
Note: Δ, change.
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of adherence to the energy goal (50%) occurred at week 3; 
adherence continually declined thereafter. Less than 40% 
of participants achieved the prescribed fat gram goal in the 
first three weeks; 22% continued to be adherent at the end 
of the weekly sessions, and the percent adherent decreased 
to 10% at 12 months.
In the first six months, a significant nonlinear decline was 
found in adherence to attendance; a significant linear decline 
was found in adherence to self-monitoring and the energy 
goal; a significant linear and nonlinear decline was found in 
adherence to the exercise and the fat gram goals (all ts 2.25 
and ps  0.0001). However, in the second six months, only 
a significant linear decline was observed to all intervention 
components (all ts  2.22 and ps  0.0001).
Adherence and weight change
In the first six months, the mean weight loss from baseline was 
-9.42 ± 5.93% (-8.81 ± 5.96 kg). Using univariate regression 
Table 1 Measures of weight and biomarkers at baseline, 6, and 12 months
Measures Baseline (n = 151) 6 months (n = 151) 12 months (n = 127)
Mean ± SD (min, max) Mean ± SD (min, max) Mean ± SD (min, max)
Weight (kg) 94.18 ± 14.51 (67.62, 136.30) 85.81 ± 14.62 (49.44,123.0) 85.28 ± 14.71 (52.35, 118.20)
insulin (µmol/L) 18.30 ± 8.20 (2.60, 52.30) 14.10 ± 5.93 (2.00, 33.80) 14.90 ± 7.21 (2.70, 44.80)
LDL (mg/dL) 123.8 ± 35.11 (25.90, 216.60) 122.1 ± 35.52 (21.50, 230.20) 120.70 ± 34.18 (44.00, 210.60)
hDL (mg/dL)a
 Males 41.68 ± 8.59 (27.30, 62.00) 43.89 ± 10.22 (28.80, 73.90) 44.49 ± 7.64 (30.00, 58.70)
 Females 54.12 ± 11.19 (30.70, 84.40) 51.50 ± 10.65 (28.90, 83.00) 55.15 ± 12.26 (27.40, 84.20)
Triglycerides (mg/dL)b
 Males 196.3 ± 110.5 (49.00, 457.00) 121.2 ± 60.15 (56.00, 279.00) 139.6 ± 63.04 (57.00, 316.00)
 Females 125.5 ± 58.97 (45.00, 389.00) 121.9 ± 55.69 (45.00, 342.00) 117.8 ± 56.87 (43.00, 419.00)
Notes: a,b19 males and 132 females at baseline and 6 months; 18 males and 109 females at 12 months.
Abbreviations: LDL, low-density lipoprotein; hDL, high-density lipoprotein; sD, standard deviation.
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Figure 2 Proportion of participants adherent to the five treatment components (N = 176).
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models controlling for the effect of time, we found greater 
weight loss was significantly associated with greater attendance, 
more frequent self-monitoring, and higher adherence to exer-
cise and energy goals (P for all  0.0001) (Table 2). However, 
no significant difference in weight loss was observed between 
those who were adherent and those who were not adherent 
to the fat gram goal. The final multiple regression model 
with percent weight change as a dependent variable indicated 
significant associations with more frequent self-monitoring 
(P = 0.004), greater attendance (P = 0.005) and adherence to 
the energy goal (P = 0.032). A marginally significant associa-
tion was also observed between adherence to the exercise goal 
and percent weight change (P = 0.07) (Table 3).
Following the less-intensive intervention phase 
(at 12-month), the mean weight change from six months was 
0.23 ± 4.35% (0.20 ± 3.56 kg). As indicated by the univariate 
regression models, a significantly greater weight loss or main-
tenance was observed among attendees (P = 0.001), those who 
were more adherent to self-monitoring (P = 0.03) and those 
with greater adherence to the exercise goal (P = 0.003). There 
was a marginally significant difference in weight loss between 
adherers to the energy goal and non-adherers (P = 0.09), but 
there was no difference in weight loss or weight maintenance 
related to fat gram goal adherence (Table 2). Table 3, the 
multiple regression model revealed significant associations 
between weight loss and greater attendance (P = 0.005) and 
weight loss and adherence to the exercise goal (P = 0.014) 
(Table 2). Participants excluded from the analysis during the 
intensive (n = 37) and less-intensive (n = 70) phases had a sig-
nificantly higher BMI (P = 0.02) at baseline than participants 
included in the analysis. Other variables including gender, 
race, and age did not differ between the two groups.
Adherence and biomarkers
During the intensive phase, the median change in biomarkers 
from baseline were -2.5% for LDL (interquartile range 
[IQR]: -14.3, 11.21%), -3.45% for triglycerides (IQR: 
-23.1, 13.7%), -2.9% for HDL (IQR: -11.7, 5.4%), and 
-23.1% for insulin (IQR: -33.7, 4.8%). As indicated by the 
Sobel test, adherence to fat gram goal was not significantly 
related to any biomarkers. However, significant indirect 
effects through weight change were noted for some adherence 
components on selected biomarkers: attendance with changes 
in LDL (95% confidence interval [CI] = -23.55, -8.30), 
triglycerides (95% CI = -50.11, -11.27) and insulin (95% 
CI = -37.85, -15.11); adherence to self-monitoring with 
changes in LDL (95% CI = -30.62, 12.31), triglycerides (95% 
CI = -40.93, -8.45) and insulin (95% CI = -30.62, -12.31); and 
adherence to the exercise goal with changes in LDL (95% CI 
= -15.37, -5.48), triglycerides (95% CI = -24.31, -5.22), and 
insulin (95% CI = -28.33, -10.53). Adherence to the fat gram 
goal had no indirect effect on any biomarkers (Table 4). The 
direct and indirect effects of HDL on adherence measures were 
not explored in the first six months because of an initial decline 
in HDL level, an expected phenomenon during weight loss.
At the 12-month assessment, the median change in bio-
markers from six months was: 1.02% for LDL (IQR: -12.9, 
13.34%), 0.43% for triglycerides (IQR: -20.8, 28.77%), 
5.04% for HDL (IQR: -2.73, 15.96%), and 8.57% for insulin 
(IQR: -10.3, 31.94%). The Sobel test revealed no significant 
direct or indirect effect of each adherence component on 
biomarkers during the less-intensive phase. We observed no 
differences in race, gender, age, or BMI among participants 
who were excluded at six and 12 months when compared 
with participants included in the analysis.
Discussion
The present study examined adherence to a behavioral weight-
loss intervention and how adherence to these intervention 
components was related to weight loss and biomarkers in a 
weight-loss trial. The findings suggest that adherence declines 
even during the intensive phase. Adherence to attendance, 
Table 2 Univariate regression modelsa of measures of adherence as predictors of percent weight change
Adherence 
components
Intensive intervention phase 0–6 months  
(n = 139)
Less-intensive intervention phase 7–12 
months (n = 106)
Estimate SE t(P) Estimate SE t(P)
Attendance 0.19 0.04 4.68 (0.0001) 0.30 0.09 3.25 (0.001)
self-monitoring 0.25 0.04 6.91 (0.0001) 0.17 0.08 2.12 (0.03)
exercise goal 0.15 0.03 4.74 (0.0001) 0.24 0.08 2.96 (0.003)
calorie goal 0.17 0.03 5.33 (0.0001) 0.14 0.08 1.67 (0.09)
Fat gram goal -0.02 0.04 0.76 (0.44) -0.01 0.09 -1.4 (0.89)
Note: aModels adjusted for the effect of function of time (square root).
Abbreviation: se, standard error.
Patient Preference and Adherence 2009:3158
Acharya et al Dovepress
submit your manuscript | www.dovepress.com
Dovepress 
self-monitoring and the energy goal was positively associated 
with weight loss during the intensive intervention phase. 
Similarly, positive associations between attendance and 
adherence to exercise and weight loss were observed during 
the less-intensive phase. Indirect effects of adherence were 
observed with the improvement in biomarkers indicating a 
mediation effect through weight loss.
We observed the maximum weight reduction and 
improvements in biomarkers (except HDL) during the first six 
months followed by weight maintenance during the second six 
months. Attendance had the highest rate of adherence with the 
least decline whereas adherence to the fat gram goal was the 
lowest at all times. Our findings, significantly greater weight 
loss with greater protocol adherence, are consistent with the 
findings of others who have reported greater weight loss with 
better attendance,9,10 self-monitoring,10,16,24 and adherence to 
the energy goal.12 Hollis and colleagues15 reported a greater 
weight loss with higher attendance, frequent self-monitoring 
and adherence to exercise. These cumulative results indicate 
that adherence to multiple treatment components is necessary 
to achieve successful weight loss.
During the less-intensive phase, weight maintenance was 
significantly associated with greater attendance and adher-
ence to the exercise goal. The beneficial effects of regular 
exercise on successful weight loss25,26 and weight maintenance 
are well established.27 Our findings also emphasize the 
importance of adherence to the exercise regimen to be 
successful in maintaining weight loss. The nonsignificant 
findings between self-monitoring, adherence to energy 
goal, and weight change may be explained by the continued 
decline in self-monitoring over time. Since attendance was 
the only adherence component that was positively associated 
with weight loss during both the intensive and less-intensive 
intervention phases, it might be used as an indicator of overall 
declining adherence during the intervention period.
We also examined the effect of each adherence compo-
nent on the biomarkers and found that adherence to self-
monitoring and the exercise goal had indirect effects on 
the improvement of biomarkers during the intensive phase. 
These findings suggest that the effects of self-monitoring 
and exercise are manifested through a mediating role of 
weight loss on biomarkers. Higher levels of adherence to 
self-monitoring and exercise resulted in greater weight 
loss, which in turn led to improvement in biomarkers. The 
indirect effect of adherence components on biomarkers is 
further strengthened by the lack of such associations during 
the less-intensive phase since no significant weight change 
was observed during that period.
We did not find a significant association between adher-
ence to the fat gram goal and weight loss, nor did we observe 
Table 3 Final multivariate regression modelsa of the set of adherence components as predictors of percent weight change
Adherence 
measures
Intensive intervention phase 0–6 months  
(n = 139)
Less-intensive intervention phase 7–12 months 
( n = 106)
Estimate SE t(P) Estimate SE t(P)
Attendance 0.12 0.04 2.81 (0.005) 0.26 0.09 2.79 (0.0054)
self-monitoring 0.14 0.05 2.88 (0.004) – – –
exercise goal 0.06 0.03 1.79 (0.07) 0.20 0.08 2.47 (0.01)
calorie goal 0.08 0.04 2.15 (0.03) – – –
Notes: Parsimonious model did not include self-monitoring and calorie goal in the less-intensive phase; aModels adjusted for the effect of function of time (square root).
Abbreviation: se, standard error.
Table 4 indirect bootstrapping effects of proportion of each adherence component on percent change in biomarkers through percent 
weight change (n = 151)a,b
Biomarkers Adherence measures during the intensive phase
Attendance Self-monitoring Exercise
Mean SE 95% CI Mean SE 95% CI Mean SE 95% CI
Low density lipoprotein 
(mg/dL)
-15.03 3.85 -23.55,  -8.30 -20.90 4.71 -30.62,  -12.31 -9.91 2.50 -15.37,  -5.48
Triglycerides (mg/dL) -27.51 9.98 -50.11,  -11.27 -22.71 8.16 -40.93,  -8.45 -13.98 4.86 -24.31,  -5.22
insulin (mg/dL) -25.39 5.79 -37.85,  -15.11 -20.90 4.71 -30.62,  -12.31 -18.57 4.63 -28.33,  -10.53
Notes: aNo direct significant effect of adherence measures on biomarkers were observed; bOnly effects where ci did not include 0 (P  0.05) are reported.
Abbreviations: CI, confidence interval; SE, standard error.
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a direct or indirect effect of adherence to the fat gram goal on 
biomarkers. This might have been due to the very low adher-
ence to this goal. A low-fat diet is viewed as less appetizing and 
satiating28 and thus might have been the most difficult compo-
nent for participants to implement and sustain. Azadbakht and 
colleagues29 reported that the moderate-fat diet (30% energy) 
group was more successful in reducing weight and other 
cardiovascular risks than the low-fat diet (20% energy) group. 
Similarly, Shai and colleagues18 suggested that the Mediter-
ranean and low-carbohydrate diets might be more effective 
than the low-fat diet for achieving more favorable changes in 
weight and lipid levels. Hence, it is possible that individuals 
might be more likely to reduce their fat intake for the long 
term if they adopt a moderate-fat diet consisting of unsaturated 
fatty acids as opposed to a standard low-fat diet.
The findings of  this study have implications for researchers 
and clinicians mainly that greater attention needs to be given 
to enhancing adherence to all components of the SBT protocol 
for improved reduction of weight and related cardiovascular 
risks. Although adherence to treatment components contrib-
uted significantly to successful weight loss and improvement 
in biomarkers, it was very difficult for participants to remain 
adherent. Considering the wide variation in adherence to the 
treatment components, exploring individualized strategies to 
improve adherence in future studies is important.
A growing body of evidence suggests that adherence to 
the treatment protocol declines over time6,12,16 indicating the 
need for innovative strategies to enhance adherence. One 
such strategy could be the incorporation of motivational inter-
viewing to augment the existing intervention. Motivational 
interviewing has been associated with greater adherence to 
treatment and follow-up in a weight-loss program30 and with 
increased adherence to dietary goals.31 Other strategies, such as 
setting individual goals, being rewarded for progress attained 
and receiving feedback and reinforcement were successful in 
the Diabetes Prevention Program and should be incorporated 
into other behavior change programs targeting weight loss. 
Future studies should also focus on developing approaches 
that decrease the burden of self-monitoring for individuals 
seeking weight loss. The Women’s Health Initiative dietary 
intervention developed self-monitoring options, such as the 
picture tracker (a graphic tool to count fruit/vegetable and 
grain servings) and the eating patterns questionnaires (tool to 
track changes in behaviors related to low-fat eating).32 The use 
of personal digital assistants with dietary software has also 
been explored as an alternative to traditional self-monitoring 
approach.33–35 These approaches should be integrated in future 
weight loss studies in order to enhance adherence.
The main limitation of this study was the reliance on 
self-report measures. Attendance was the only objective 
measure of adherence. The generalizability of these findings 
may be limited due to the predominantly female sample; 
however, the sample included 18% males, and moreover, 
29% minorities. Additionally, the proportion of the sample 
that was adherent during the later phase was smaller during 
the less-intensive phase, thus may have been inadequate to 
detect statistically significant differences. A major strength of 
the study was the comprehensive examination of adherence 
to each component of the weight-loss treatment protocol 
for 12 months. The retention rate of 74% at the 12-month 
assessment was comparable or better than rates reported for 
other weight-loss studies.6,36 Despite declining adherence, 
all groups lost weight (0.54 kg to 33.61 kg).
Conclusion
A steady decline in adherence even during the intervention 
period indicates that it is difficult for participants to sustain 
the behavior changes required for treatment goal achieve-
ment. Our findings reveal greater attendance and adherence 
to self-monitoring, exercise, and calorie goals contribute to 
successful weight loss and maintenance. Moreover, improve-
ments in biomarker measures are achieved through weight 
loss. Some additional strategies, such as individual support, 
motivational interviewing and the use of less burdensome 
self-monitoring tools should be explored in future studies to 
achieve optimal adherence to the treatment protocol.
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